Gilead Historical Income Statement
| 0QYQ Stock | 92.82 0.27 0.29% |
Historical analysis of Gilead Sciences income statement accounts such as Interest Income of 1.3 B, Interest Expense of 0.0 or Selling General Administrative of 5 B can show how well Gilead Sciences performed in making a profits. Evaluating Gilead Sciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Gilead Sciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Gilead Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Gilead Sciences is a good buy for the upcoming year.
Gilead |
About Gilead Income Statement Analysis
Gilead Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Gilead Sciences shareholders. The income statement also shows Gilead investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Gilead Sciences Income Statement Chart
Total Revenue
Total revenue comprises all receipts Gilead Sciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Gilead Sciences minus its cost of goods sold. It is profit before Gilead Sciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Operating Income
Operating Income is the amount of profit realized from Gilead Sciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Gilead Sciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Gilead Sciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Gilead Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Gilead Stock please use our How to Invest in Gilead Sciences guide.At this time, Gilead Sciences' Interest Income is comparatively stable compared to the past year. Income Tax Expense is likely to gain to about 1.5 B in 2024, whereas Tax Provision is likely to drop slightly above 1.5 B in 2024.
| 2020 | 2021 | 2023 | 2024 (projected) | Gross Profit | 20.1B | 20.7B | 23.8B | 21.5B | Total Revenue | 24.7B | 27.3B | 31.4B | 27.0B |
Gilead Sciences income statement Correlations
Click cells to compare fundamentals
Gilead Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Gilead Sciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 2.3B | (204M) | 1.6B | 2.1B | 1.9B | 1.5B | |
| Interest Income | 964M | 227M | 2.7B | 1.0B | 1.2B | 1.3B | |
| Selling General Administrative | 4.1B | 4.4B | 5.2B | 5.2B | 6.0B | 5.0B | |
| Total Revenue | 22.1B | 22.4B | 24.7B | 27.3B | 31.4B | 27.0B | |
| Gross Profit | 17.3B | 17.8B | 20.1B | 20.7B | 23.8B | 21.5B | |
| Operating Income | 8.2B | 4.3B | 4.1B | 9.9B | 8.9B | 6.5B | |
| Cost Of Revenue | 4.9B | 4.7B | 4.6B | 6.6B | 7.6B | 5.5B | |
| Income Before Tax | 7.8B | 5.2B | 1.7B | 8.3B | 7.5B | 5.8B | |
| Net Income Applicable To Common Shares | 5.4B | 123M | 6.2B | 4.6B | 4.1B | 3.5B | |
| Net Income | 5.5B | 5.4B | 123M | 6.2B | 5.6B | 3.5B | |
| Ebit | 9.3B | 11.0B | 11.9B | 11.0B | 12.6B | 11.6B | |
| Income Tax Expense | (204M) | 1.6B | 2.1B | 1.2B | 1.4B | 1.5B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Gilead Stock Analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.